Additionally, alterations in expression of target genes including ABCB1 and CYP3A4 in breast cancer patients, which subsequently results in altered clearance of xenobiotics and drug substrates, have been linked with PXR polymorphisms [72,73]. Here, NR1I2 is linked to breast carcinoma.